Figure 2: (a) 7^th day Ankaferd Blood Stopper group; hematoxylin-eosin staining bar 100μm, (b) 7^th day caffeic acid phenethyl ester group; hematoxylin-eosin staining bar 100 μm, (c) 7^th day control group; hematoxylin-eosin staining 100 μm, (d) 14^th day Ankaferd Blood Stopper group; hematoxylin-eosin staining bar 100 μm, (e) 14^th day caffeic acid phenethyl ester group; hematoxylin-eosin staining bar 100 μm, (f) 14^th day control group; hematoxylin-eosin staining 100 μm, (g) 21^st day Ankaferd Blood Stopper group; hematoxylin-eosin staining bar 100 μm, (h) 21^st day caffeic acid phenethyl ester group; hematoxylin-eosin staining bar 100 μm, (i) 21^st day control group; hematoxylin-eosin staining 100 μm